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Abstract
Purpose To delineate the historical steps associated
with the genesis of the name and the definition of
Vogt–Koyanagi–Harada (VKH) disease.
Methods A bibliographical review of the major
publications that were relevant to the original devel-
opment of the name of the clinical entity known
today as Vogt–Koyanagi–Harada disease, in the
historical context of the early 20th century.
Results Three distinct time periods can be consid-
ered to be important in terms of providing a historical
perspective on VKH disease. Given that the cutane-
ous manifestations of VKH disease are so character-
istic, these could not have been missed even before
the actual clinical entity of VKH was recognized in
the early 20th century. Indeed, several authors,
including the Arabic doctor Mohammad-al-Ghaˆfiqıˆ
in the 12th century as well as Jacobi, Nettelship and
Tay in the 19th century, described poliosis, neuralgias
and hearing disorders. Many of these cases were
probably due to sympathetic ophthalmia, but some
were clearly VKH cases. The second phase is
characterized by the surge of articles that appeared
early in the 20th century that defined the disease more
precisely. A number of these authors subsequently
became associated with the disease name, the first
being Alfred Vogt from Switzerland, followed by
Japanese researchers. Yoshizo Koyanagi was in fact
not the first Japanese author to describe the disease;
this honor goes to the first Japanese Professor of
Ophthalmology at the University of Tokyo, Dr. Jujiro
Komoto, who published in a German language
journal, Klinische Monatsbla¨tter fu¨r Augenheilkunde
in 1911. Yoshizo Koyanagi published his first report
in the Nippon Ganka Gakkai Zasshi 3 years later, in
1914, but it was a much later article, one published in
1929, that definitively associated his name with the
disease. In this review article, Koyanagi reported 16
cases, of which six were his own cases, that
beautifully illustrate the natural course of the disease.
In this same time period, Einosuke Harada, in an
article published in Nippon Ganka Gakkai Zasshi in
1926 that was based on several case studies,
comprehensively described a syndrome that included
(1) a prodromal phase of malaise and meningeal
irritation; (2) bilateral uveitis of diverse intensity; (3)
bilateral retinal detachments spontaneously resolving;
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(4) integumentary changes; (5) lymphocytosis of the
spinal fluid; (6) dysacousia. It is now accepted that
Vogt–Koyanagi disease and the syndrome described
by Harada are one entity with a diverse clinical
spectrum bearing the universally accepted name of
Vogt–Koyanagi–Harada disease. The third phase and
most recent phase is characterized by the rapid
progress made in terms of knowledge of the physio-
pathology of the disease, primarily due to the
development of immunological methods. The evi-
dence accumulated to date clearly points towards an
autoimmune Th1 disease directed against proteins
associated with choroidal melanin. Other analytical
techniques, such as indocyanine green angiography,
have enabled researchers to monitor more closely the
primary lesional process at the level of the choroid,
and standardized diagnostic criteria have been gen-
erated in the recent past.
Conclusion Those who earn scientific merit in
clinical medicine are the ones who are able to
visualize an overview based on the synthesis of ‘new’
medical facts that have been made available, usually
reported singly by several, unassociated authors
concomitantly. This is certainly the case for Yoshizo
Koyanagi and Einosuke Harada. Conversely, Alfred
Vogt was primarily lucky in that he encountered and
subsequently precisely described the first case in the
literature.
Keywords History  Japan  Switzerland  Vogt–
Koyanagi–Harada disease
Introduction
In this historical essay, which takes both personalities
and historical background into account, the authors
relate the Swiss and Japanese points of view on how the
name Vogt–Koyanagi–Harada disease came into
being. This eponym designates a fascinating disease
that is still unveiling its secrets as immunological
research and progress in investigational methods
enable researchers to gain a better understanding of
the genesis of the disease and its mechanisms. The sole
player in the first act in terms of defining Vogt–
Koyanagi–Harada (VKH) disease was the Swiss
ophthalmologist Alfred Vogt, who, in 1906, when he
was still a resident in the Department of Ophthalmol-
ogy of Basel University Hospital, published a case
report in which he described what is now known as
VKH disease for the first time [1]. The second act
occurred on the opposite side of the world, in Japan,
where Western medicine was barely 40 years old:
several Japanese authors described different aspects of
the disease, and the names of Yoshizo Koyanagi and
Einosuke Harada remain figuratively attached to the
disease that today is described comprehensively as a
bilateral granulomatous uveitis that initially can
involve only the posterior segment or can present as a
panuveitis and which is most probably caused by a Th1
autoimmune reaction against proteins related with
stromal choroidal melanocytes [2–3]. The fact that the
name of a Swiss ophthalmologist, Alfred Vogt, is
linked to the names of two Japanese ophthalmologists,
Yoshizo Koyanagi and Einosuke Harada, should be put
into the proper historical perspective and medical
historical context of the beginning of the 20th century,
both in Europe and Japan.
The ‘pre-VKH’ reports
The depigmentation of eyelashes and eyebrows is
such a remarkable and peculiar finding that it has
been readily recorded and described in the past. In the
12th century, the Arabic doctor Mohammad-al-
Ghaˆfiqıˆ mentions the occurrence of poliosis in his
book on eye diseases [4]. In the 19th century, poliosis
is described by several authors and associated with a
nervous choc, neuralgias or a physical trauma [5–7].
It can be hypothesized that some of these descriptions
possibly represented VKH disease as (1) neuralgias
might have corresponded to the headaches usually
associated with VKH and (2) trauma, even to body
parts distant from the eye, has been shown in the past
and also recently to possibly be at the origin of VKH
cases [8]. However, poliosis of the eyelashes and
eyebrows together with hearing problems were the
more frequent symptoms associated with sympathetic
ophthalmia [9–10].
The medico-historical context of Japanese
ophthalmology in the early 20th century
In order to realize how quickly Japanese medicine in
general and Japanese ophthalmology in particular
closed the immense gap that had been generated by
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the 250 years of closed border policy of the
Tokugawa period (1600–1868), it is necessary to
make a quick digression into general history.
In January 1867 a new emperor acceded to the
Japanese throne. He took the name of Meiji
(enlightened rule), and his reign signaled the
beginning of an era that would see radical changes
in all aspects of Japanese life, including those that
comprehensively determined Japanese medical des-
tiny. This emperor was aged only 15 at the time he
became emperor, and his destiny was to be taken
into custody by the political forces fiercely opposed
to the 250-year-long Tokugawa military (samurai)
government, which had been judged to be too inapt
to deal with the foreign pressures on Japan [11]. On
January 3, 1868, these forces, primarily from the
southern provinces which had been kept out of state
affairs during the past 250 years, occupied the
imperial palace and declared imperial rule in the
name of the emperor. The last Tokugawa shogun, in
place only 1 year and despite his having contributed
to the positive evolution and modernization of the
nation, preferred to relinquish power. By so doing,
Tokugawa Yoshinobu, a progressively oriented and
very distinguished personality – and one forgotten
by history – probably made a very significant
contribution to the modernization of Japan by
avoiding a potentially devastating civil war that
would have postponed Japanese modernization by
years [12]. It has to be pointed out, however, that
contrary to what is currently believed, the political
forces that are now credited for the modernization of
Japan performed their ‘coup d’e´tat’ for precisely the
opposite motives: they wanted to overthrow Tokug-
awa Yoshinobu because they judged him too
progressive as shown by his signing treaties with
foreigners; in contrast, the new political forces
wished to keep the country closed to outside
influences. However, events would push them to
do exactly what the last shogun had begun, mod-
ernization through intense contacts and learning
from foreigners. A very determined and carefully
planned exploration of the best sources to acquire
western know-how in all domains was put on track
and resulted in the construction of a modern and
powerful nation that defeated Imperial Russia in the
Russo-Japanese war at the beginning of the 20th
century. This fast-pace modernization also contrib-
uted to the development of (Western) medicine.
On March 8, 1868 the new government issued a
decree saying ‘Western medicine has been prohibited
in the Imperial Court, but its advanced part may
hereafter be adopted’ [13]. Jun Iwasa, who had been
taught medicine in Japan by Antonius Franciscus
Bauduin, a Dutch teacher of medicine whose family
was originally from France, was appointed by the
new government as the officer in charge of medical
education. It was now the task of the Bureau of
Medical Affairs, created and headed by Jun Iwasa
since January 23, 1869, to choose the foreign medical
educational system that would be imported into
Japan. At that time, three influential Western teachers
of medicine, Antonius Franziskus Bauduin and Guido
Herman Fridolin Verbeck from the Netherlands and
William Willis, a British physician, advised the
Japanese to adopt the German medical educational
system. The large Japanese interdisciplinary delega-
tion headed by Tomomi Iwakura that embarked on a
round-the-world journey on October 8, 1871 to study
all the vital aspects and systems, including educa-
tional and medical systems of Western nations, also
stopped in Germany and established the basis of what
would become a very close relationship in the
medical field until the end of World War II. Many
Japanese doctors received their medical education
and specialization in German medical schools, and
many German medical teachers came to Japan. The
German language was adopted for all medical
matters, and it became quite natural for Japanese
doctors to publish their research in German medical
journals. Therefore, it is no surprise that the original
article on VKH disease by the German-speaking
Swiss ophthalmologist Alfred Vogt in 1906 and that
of Yoshizo Koyanagi in 1929, in which he exten-
sively reviews 16 VKH cases, were published in the
same German journal Klinische Monatsbla¨tter fu¨r
Augenheilkunde.
In the ophthalmological field, Kinnojo Ume was
the first Japanese lecturer, replacing a German
teacher in 1883 after he had returned from Germany;
following the death of Kinnojo Ume, his position at
Tokyo University was filled by Jujiro Komoto, also
trained in Germany, who subsequently became the
first appointed Professor of Ophthalmology in 1889.
In 1893, Jujiro Komoto published the first Japanese
textbook for ophthalmology. The Japanese Society of
Ophthalmology was founded in 1896, with Professor
Komoto as its first president, and the first congress
Int Ophthalmol (2007) 27:67–79 69
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was held in February 1897, which is also the first year
that its journal was published (Nippon Ganka Gakkai
Zasshi). One of the historical events that had a direct
influence on Japanese ophthalmology was the Russo-
Japanese war: Japanese ophthalmologists became
experts in sympathetic ophthalmia, a clinical picture
to which the first cases of VKH were compared, with
the difference that no traumatism occurred in the
latter.
The first act, Switzerland
The article princeps (1906) (Fig. 1)
In 1906, at the age of 27, Alfred Vogt, who was still a
resident in the department of ophthalmology at Basel
University Hospital in northern Switzerland, pub-
lished a case report which he entitled ‘Premature
whitening of eyelashes and comments about the so-
called sudden onset of this change’ [1]. Vogt
published his case report in Klinische Monatsbla¨tter
fu¨r Augenheilkunde. The patient was an 18-year-old
peasant. Although the ethnic origin of the patient is
not given, based on the published photograph he
seems to have a dark complexion, and his face does
not appear to have a northern Caucasian countenance
but more of a Southern, Middle Eastern or North
African one (Fig. 2). The article was 14 pages long,
and the part devoted to uveitis takes up exactly five
lines and can be translated from German as follows:
‘The eyeballs with ciliary injection showed the usual
image of subacute iridocyclitis. Because of the
exudates and the keratic precipitates, the previous
visual acuity reported as normal, was decreased to 4/
200 on the right and 3/200 on the left side. The
inflammation was resistant to all therapeutical
attempts, in as much as apparent resolution of
inflammation was always followed by new exacerba-
tions’. The remainder of the report (14 pages minus
these five lines) are nearly exclusively devoted to the
possible genesis of the whitening of eyelashes and
whether they appear all of a sudden or take some time
to develop and become apparent. His literature search
also does not concentrate on uveitis but only on
reported cases of eyelash whitening (poliosis). The
literal translation of the term poliosis from Greek is
‘becoming grey’. Vogt then reports cases of poliosis
reported in the literature, most of which were
associated with sympathetic ophthalmia. The absence
of any comment and even the absence of interest of
Vogt for the uveitis or other complications, such as
dysacousis, indicates that he put his finger on this first
described case of VKH disease quite by chance and
that he was not really aware of all the intraocular
inflammatory implications of the case which, in fact,
he merely described with precision, mainly focusing
on the eyelash problem.
Alfred Vogt and Swiss ophthalmology in the first
third of the 20th century
Alfred Vogt (1879–1943) (Fig. 3) [14–15]
Alfred Vogt was born in 1879, 1 year earlier than
Yoshizo Koyanagi (1880) and 13 years earlier than
Einosuke Harada (1892), in the canton of Argau in
the German-speaking region of northern Switzerland.
He attended medical school at the universities ofFig. 1 First page of the article written by Alfred Vogt in 1906
Fig. 2 Face of the first patient with Vogt–Koyanagi–Harada
(VKH) disease described by Alfred Vogt in his 1906 article
showing bilateral eyelash discoloration (poliosis)
70 Int Ophthalmol (2007) 27:67–79
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Zurich and then Basel, where he graduated in 1904 at
the age of 25. He received his ophthalmological
training from 1904 to 1906 in Basel. It was during
this period, when he was still a ‘medical resident’ that
he reported the first case of an entity that would
eventually be designated Vogt–Koyanagi–Harada
disease [1]. From 1906 to 1917 he returned to his
canton of Argau, where he became the director of the
Department of Ophthalmology of the Kantonsspital
(County Hospital). During this period he carried out
notable work on the yellow coloration of the macula,
which since 1945 is known to be due to intracellular
xantophyll pigment. In 1917 he was nominated to
become the chairman of the Department of Ophthal-
mology of Basel University Hospital, as yet without
completing his thesis (Fig. 4).
The government of Canton Basel nominated Vogt
against the will of the Medical Faculty. His relations
with the Basel Medical Faculty were not excellent,
and the value of his scientific work was not appre-
ciated and judged too ‘specialistic’ and morphology-
stic’, whatever this may mean. In 1921 he published
the first edition of what would become a monument
in three volumes of didactic ophthalmology entitled
Atlas of slit-lamp microscopy of the living eye
(Fig. 5).
Because of the cold response of the Medical
Faculty and failing recognition for his work in Basel,
he did not hesitate one moment to accept the
chairmanship of the Department of Ophthalmology
of Zurich University Hospital, which was offered to
him in 1923, declining even to hold a farewell dinner
in Basel. His welcome lecture in Zurich was on the
Fig. 3 Alfred Vogt (1879–1943)
Fig. 4 Basel University Eye Clinic at the beginning of the
20th century
Fig. 5 First volume (second edition) of Vogt’s Atlas of slit-
lamp examination of the eye published in 1930
Int Ophthalmol (2007) 27:67–79 71
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physiological and pathological effects of light rays on
the eye, indicating his interest in the different factors
at the origin of the development of cataracts. During
his time in Zurich, publications followed one after
another on slit-lamp findings, describing the cornea
guttata, cataracta centralis pulverata, persistence of
anterior hyaloid membrane, chalkosis and siderosis of
the lens, the degeneration of the papillo-macular
nerve-fiber bundle and many other aspects. For his
work in these areas, he received in 1937 the Donders-
medall from the Dutch Ophthalmological Society. He
was furthermore awarded the Gullstrand-medall and
in 1941 the Gonin-medall. During the second world
war he generously supported and contributed to the
survival of Klinische Monatsbla¨tter fu¨r Augenheilk-
unde, the journal that has contributed so much to the
exchanges between Japanese ophthalmologists and
their colleagues in German-speaking Europe. He
remained as chairman of the Department of Ophthal-
mology in Zurich until August 1943; however, due to
failing health, the practical day-to-day tasks had been
taken over by Professor Wagner in the fall of 1942.
Alfred Vogt died on December 10, 1943.
Swiss ophthalmology in the first third of the 20th
century [16]
At the beginning of the 20th century, there were five
medical schools and university hospitals in Switzer-
land – in the cities of Basel, Bern, Geneva, Lausanne
and Zurich, respectively.
The departments of ophthalmology of these med-
ical institutions provided the sound foundations on
which modern Swiss ophthalmology has based its
quality and success from the 1930s onwards. The
strong personality of Alfred Vogt left its mark on the
departments of ophthalmology in Zurich and Basel
during the first third of the 20th century. In Bern, the
first third of the 20th century was marked by the
construction of a large and modern new eye hospital
that became functional at the end of the first decade,
and it is due to the presence of such a large and well-
equipped eye hospital that the significant scientific
contributions of Hans Goldman emerged. Hans
Golmann was appointed chairman in 1935. His name
is directly associated with the development of
indispensable investigative instruments that are still
used every day in practice, such as the Goldmann
applanation tonometer and the Goldmann visual field.
In Geneva, the first eye hospital built at the end of the
19th century was not associated with the university
hospital. It was a hospital offered to the city by the
baron Adolphe de Rothschild, who had been treated
in Geneva for a corneal foreign body during one of
his trips. This hospital continued in operation even
after the university eye hospital was built in 1921 and
it now functions as the Memorial A. de Rothschild,
the main private ophthalmological facility in Geneva.
In 1933, Adolphe Franceschetti was appointed chair-
man in Geneva and marked the apogee of the Geneva
Department of Ophthalmology with pioneering work
in oculogenetics. Ophthalmology in Lausanne was
marked by the foundation in 1843 of the ‘Fondation
Asile des Aveugles’ (Foundation Home for the
Blind). When the medical school was founded in
1890, the Department of Ophthalmology of the
University of Lausanne was run by the ‘Foundation’,
and its medical director was also the chairman of the
Department of Ophthalmology. In 1918, Jules Gonin
became the new medical director of the hospital of
the Foundation, but the university appointed a French
professor and opened a department of ophthalmology
within the university hospital. The reputation of the
‘Foundation’ hospital was such, however, that the
university had to close down its department 2 years
later, and Jules Gonin was named Professor of
Ophthalmology in 1920 in addition being director
of the ‘Foundation’ hospital. During the 1920s Jules
Gonin discovered the pathogenesis of ‘idiopathic’
(rhegmatogenous) retinal detachment and its surgical
treatment. Jules Gonin had the greatest difficulties
getting his work accepted and was even considered to
be a heretic when he proposed displacing the wall of
the eye towards the retina to repair retinal detach-
ment. It is now accepted universally that he is the
father of retinal detachment surgery and the Lausanne
University Eye Hospital (Hoˆpital Jules Gonin), a
scientific society (the Club Jules Gonin) and a
prestigious Medall-award (the Jules Gonin medall)
are named after him.
On the national level, the Swiss Society of
Ophthalmology was founded in 1908, 11 years after
the foundation of the Japanese Society of Ophthal-
mology, and it is celebrating its 100th anniversary
this year in 2007. That such a national society was
established relatively late can be explained by the fact
that, academically, the Swiss ophthalmologists at the
end of the 19th century were educated abroad and
72 Int Ophthalmol (2007) 27:67–79
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turned towards Germany for German-speaking Swiss
ophthalmologists and towards France for the French-
speaking Swiss ophthalmologists. Thus, the Swiss
ophthalmologist Friederich Horner was a founding
member together with von Graefe and Donders, of
the Heidelberg Ophthalmic Society, established in
1863. As was the case for the Japanese ophthalmol-
ogists, publications were sent abroad – either to
Germany to the Graefe’s Archiv fu¨r Augenheikunde,
which was founded in 1854, or to the Klinische
Monatsbla¨tter fu¨r Augenheilkunde, which was
founded in 1863, or to France, to the Annales
d’oculistique, founded in 1838. The stimulus for the
establishment of a Swiss Society of Ophthalmology
originated in the organization of the Tenth Interna-
tional Congress of Ophthalmology, in Lucerne.
Switzerland was granted the honor of hosting this
congress both in recognition of well-known Swiss
ophthalmologists and due to the influence of Swiss
ophthalmologists occupying positions abroad, such as
Professor Edmond Landolt in Paris. The two Japanese
ophthalmologists that participated in that congress
were Tatsu Naito and Genzo Hotta, the latter staying
in Breslau with Professor Uhthoff from whom he
received his ophthalmological education between
1903 and 1905. All of the renowned Swiss ophthal-
mologists, including Auguste Barde, Head of the
Rothschild Hospital in Geneva, and Marc Dufour, the
‘‘Foundation’’ hospital in Lausanne, as well as Swiss
ophthalmologists working abroad, such as Edmond
Landolt from Paris, were involved in organizing this
event in 1904, which was attended by 440 ophthal-
mologists worldwide. The germs of the future society
sprang from this congress, and it was finally founded
in 1908. The Lucerne congress was very successful
scientifically, but the congress attendants also en-
joyed excursions to the Rigi heights and its idyllic
atmosphere and panorama as well as to the Pilatus
mountain, two very popular touristic spots specially
appreciated still today by Japanese tourists.
In summary, the link between Switzerland and
Japan in terms of VKH disease is a very tiny one and
one completely determined by chance, as the first
case logically should not have been described in
Switzerland where VKH is a rare occurrence. The
fact that the patient described by Vogt was probably
of Mediterranean origin was the chance factor that
determined that the name of this entity contains a
non-Japanese name.
The second act, Japan
Early reports of Japanese cases of VKH (1911)
With the high incidence of VKH disease occurring in
Japan, it is easy to understand that most of the
pioneering work done on VKH disease comes from
Japan.
In his review article of 1929, which established the
semiology of the disease that is known today as
Vogt–Koyanagi–Harada disease, Yoshizo Koyanagi
cited his very first article on the disease and included
the two patients reported in it. This first article
appeared in the Nippon Ganka Gakkai Zashii in 1914
and described two patients presenting with a uveitis
resembling sympathetic ophthalmia but without a
history of trauma; in addition, one patient also
showed integumetary changes together with dysa-
cousis [17]. Koyanagi also cited the case reported by
Vogt in 1906 and was astonished – as we were when
we read the original article – that Vogt only showed
interest for the poliosis, giving only scarce attention
to the uveitis. In his review article, Koyanagi cites
another case that was published by J. Komoto in 1911
in the Klinische Monatsbla¨tter fu¨r Augenheilkunde,
prior to his own first case report [17, 18]. Thus, the
first Japanese description of Vogt–Koyanagi–Harada
disease has to be accredited to Jujiro Komoto (Fig. 6)
In his article, Professor Komoto describes the case a
33-year-old wife of a fish merchant that came to his
private clinic and presented the typical prodromal
systemic symptoms followed by a bilateral decrease
of vision and the occurrence of poliosis [18]. The
article describes very precisely the fundus which
corresponds to what is known today as sunset glow
fundus. Professor Komoto noticed that the fundus
resembled that of an albinotic fundus except that
there were disseminated clumps of pigment. He very
appropriately indicated that the retina itself seemed to
be relatively untouched, having noticed that the
disease involved primarily the choroid.
Fig. 6 First page of the first Japanese report of a VKH case
presented by Professor Komoto
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The review article of Yoshizo Koyanagi (1929)
(Fig. 7)
The review article which Yoshizo Koyanagi pub-
lished in 1929 in the Klinische Monatsbla¨tter fu¨r
Augenheilkunde was absolutely remarkable in several
aspects [19] (Fig. 8). In this review article he reported
his first two cases published in 1914 and added four
new cases of his own; he then went on to cite ten
cases taken from the literature, including one case
published by Hata and Harada in 1919 [20], 7 years
before Harada wrote his main article in 1926, and the
first case reported by Vogt. In his introduction,
Koyanagi expressed his astonishment that, after the
first case described by Vogt, there were absolutely no
other reports coming from outside Japan, implicitly
indicating the preponderant occurrence of the disease
in Japan. Koyanagi’s description of the disease is
precise and complete, including the prodromal phase,
the acute ocular phase with the posterior involvement
– which he calls neuroretinitis – the anterior partic-
ipation of the disease with large non-pigmented KPs
and the hypotony, which he attributes to ciliary body
inflammation (Fig. 9a). He further described the
fundus depigmentation in the convalescent phase of
the disease (Fig. 9b). He is also the first author to
unequivocally associate auditory and integumentary
manifestations to the disease entity. As no treatment
was available at that time, the article is remarkable
for its precise description of the natural course of
VKH disease. Auditory involvement was noted in 8/
16 cases and occurred concomitantly to the eye
involvement. Integumentary changes (alopecia and
poliosis) occurred in all 16 cases (100%) and
developed after a mean of 7.43 ± 3.36 weeks after
the acute episode, whereas vitiligo was only noted in
9/16 cases (56%). The only element that does not fit
with the disease profile in this review are the results
of cerebrospinal fluid (CSF) investigations, which are
reported as non-inflammatory. However, few details
are given on how many lumbar punctures were
performed and how the CSF was analyzed. As far as
the pathogenic mechanism is concerned, Koyanagi
and others were not far from the correct hypothesis of
an immune reaction against pigment, which at this
epoch was called an ‘anaphylactoid’ reaction. In
terms of the etiology, Koyanagi did not yield to the
tendency at that time of attributing many conditions
to syphilis. In the discussion section of his article his
logical conclusion and new interpretation was, in
contrast to previous and contemporary reports [10],
that the auditory and skin lesions were not a
consequence of the eye disease but resulted from
the same pathogenic mechanism at the origin of eye
disease, as auditory involvement, in particular, was
Fig. 7 Title page of the review article by Yoshizo Koyanagi
published in the year 1929
Fig. 8 Title page of volume 82 of the Klinische Monatsbla¨tter
fu¨r Augenheilkunde in which the review article of Yoshizo
Koyanagi was published in 1929
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seen to occur quasi simultaneously to the eye
involvement.
Yoshizo Koyanagi (1880–1954) (Fig. 10)
Similar to many of the Japanese historical facts
reported in this article, the biographical elements on
Professor Yoshizo Koyanagi were taken from Pro-
fessor Saiichi Mishima’s book on The History of
Ophthalmology in Japan [21]. Yoshizo Koyanagi was
born in 1880. He graduated from Kyoto Imperial
University in 1908 and studied ophthalmology under
Ikujiro Asayama, the first Professor of Ophthalmol-
ogy at Kyoto Imperial University and the first author
to describe a case of central serous chorioretinopathy.
His teacher was also the first Japanese ophthalmol-
ogist to attend an International Congress of Ophthal-
mology (the ninth congress in Utrecht in 1899).
In 1914 Yoshizo Koyanagi published a first article
on the disease that would eventually bear his name in
which he reported two patients who had all the
characteristics of VKH disease [17]. In 1915, he
became the first Professor of Ophthalmology in the
newly founded Tohoku Imperial University in Sen-
dai. In 1929, Koyanagi wrote the review article in
which he reported 16 cases of what would eventually
be known as VKH disease, ten of which were the
result of a literature search. It is this comprehensive
review article, which in fact was the first to report the
natural course of non-treated VKH disease, which
linked the name of Koyanagi to this particular ocular
inflammatory disease. Koyanagi became a world-
famous ophthalmic pathologist and gave a special
report on retinal pathology at the Fifteenth Interna-
tional Congress of Ophthalmology in Cairo in 1937.
In 1942, Yoshizo Koyanagi retired from the profes-
sorship of Tohoku Imperial University, and he died in
1954.
Harada’s disease (1926) (Fig. 11) [22, 23]
In 1923, Einosuke Harada reported a case of peculiar
uveitis, heretofore unknown; he subsequently identi-
fied three more cases in 1925 [22]. In 1926, he
reported five cases analyzed in detail, including the
four earlier cases, under the name of ‘acute diffuse
choroiditis’ in the journal Nihon Ganka Gakkai
Fig. 9 (a) Anterior involvement in VKH, (b) posterior
involvement in VKH showing sunset glow fundus. Both
drawings are taken from the 1929 article by Koyanagi
Fig. 10 Yoshizo Koyanagi (1880–1954)
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Zasshi [23]. The five patients reported by Harada
were Japanese and aged 47 (man), 24 (woman), 20
(man), 27 (woman) and 25 (man). Three patients
were from Tokyo, while the other two were from
districts away from Tokyo. Harada observed a full
clinical course in these patients from the disease
onset until a few years later, and he recognized that
the patients exhibited unique clinical appearances
which were quite different from one disease stage to
the other. He summarized the clinical pictures of the
five cases as follows.
The patients developed a sudden onset of visual
disturbance in both eyes, either simultaneously or
with a few days delay from one eye to the other. The
visual disturbance reached its peak several days after
onset. During or prior to these ocular episodes,
patients complained of headache and poor appetite,
conditions which lasted for about 1 month. Some
patients complained of nausea and vomiting on
several occasions during this period. In the acute
early stage of the disease, the cornea, anterior
chamber and the iris appeared as normal, but the
pupil was dilated and the light reflex was not prompt.
Ophthalmic examination at the acute stage revealed
neuroretinitis and later vitreous opacities and reti-
nochoroiditis. The ocular inflammation progressed
rapidly or slowly to the peripheral fundus and
developed into intense chorio-retinitis. All five
patients developed intense edema of the optic disc
and the retina near the optic disc followed by retinal
detachment near the optic disc. The patients became
hypermetropic up to 6D to 7D and had visual field
defects together with intense visual loss. With the
progress of inflammation, the exudative retinal
detachments expanded down to the inferior fundus.
Two to three months after onset, the retinal detach-
ment improved and disappeared with gradual recov-
ery of visual function. However, diffuse choroiditis
persisted and relapsed. It took several months until
complete remission of the ocular inflammation. In all
five patients, the ocular fundus after the recovery
from ocular inflammation resembled the fundus of
Caucasians in that choroidal blood vessels were
clearly visible. There were some pigment migrations,
pigment clumpings, atrophic lesions in the fundus,
atrophy of the retina and the choroid, exposure of the
sclera by fundus examination and some fibrinous
tissue formation. The visual functions of these
patients depended on the changes in the ocular
fundus in each case. Harada reported alopecia and
poliosis in one patient of his series. Lumbar puncture
was performed in three patients between day 17 and
day 19 after disease onset, and pleocytosis (described
as ‘precipitates in his manuscript) was found in one
patient. In summary, the common findings in Hara-
da’s cases were acute bilateral onset of posterior
uveitis with exudates, resulting in focal retinal
detachments. After the inflammation subsided, defuse
depigmentation became evident, and the fundus
showed a sunset glow appearance. Poliosis and
Fig. 11 First page of Harada’s main article published in 1926
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vertigo were accompanying symptoms, and there was
polycytosis in the spinal fluid. The disease often
relapsed and was seen to take a chronic course.
Similar cases were reported abroad later, and these
were called Harada’s disease [24]. Thus, the concept
of Harada’s disease became widely accepted in the
world.
Einosuke Harada (1892–1946) (Fig. 12) [21]
Einosuke Harada was born in 1892, 12 years later
than Yoshizo Koyanagi. He graduated form Tokyo
University in 1917 and became an army surgeon.
From 1923 to 1925 he studied ophthalmology as
an assistant to Professor Ishihara. He then carried out
research at the Department of Pharmacology of
Tokyo University where he completed his disserta-
tion on ‘Experimental studies on changes of the
aqueous humor by various drugs’ and received the
degree of doctor of medical sciences (DMSc) in
1929. He practiced in Nagasaki in the hospital of his
father-in-law thereafter but was drafted in 1943 to the
battlefront of the Philippines. He was later sent home
because of illness. His hospital was destroyed by the
atomic bomb on August 9, 1945.
He was planning to reopen a new hospital, but fell
ill and died in December 1946 at the age of fifty-five.
The use of the terms Vogt–Koyanagi disease
(syndrome) (1939) and Vogt–Koyanagi–Harada
disease (syndrome) (since 1955)
In 1939, Jean Babel of the Department of Ophthal-
mology of Geneva University Hospital, which had
been directed since 1933 by Adolphe Franceschetti,
reported a case corresponding to the entity described
by Koyanagi in his 1929 review article and by Vogt
in 1906 [25]. In this article, Babel carried out an
extensive literature search on the disease and pro-
posed naming it Vogt–Koyanagi syndrome. He also
indicated that the Vogt–Koyanagi syndrome and
Harada’s disease were very close, almost identical
in fact, with the exception that the systemic symp-
toms were less pronounced in Vogt–Koyanagi syn-
drome. By 1950, the two terms Vogt–Koyangi
disease (syndrome) and Harada’s disease (syndrome)
were used independently and in parallel. The term
Vogt–Koyanagi–Harada disease began to be used in
1955 in about 20% of the published articles. By 1970,
the majority of articles published used the eponym
Vogt–Koyanagi–Harada disease (syndrome) and by
2003 the quasi-totality of authors use the association
of the three names for their publications [26].
However, in Japan, in common everyday lan-
guage, such as in announcements of symposia and
workshops, the name ‘Harada byoˆ’ (Harada disease)
is used more often than the full name Vogt–Koyan-
agi–Harada disease.
Further developments
Great progress has been made in recent years in terms
of increasing our knowledge of the pathogeny of the
disease, with more precise investigational techniques
enabling optimal follow-up and better guidance in
treatment as well as facilitating a more precise
definition of the disease as far as nomenclature is
concerned. Most of this work originates in Japan. A
more detailed description of recent developments will
be the subject of a future article, and it is only
touched upon here to complete this historical
approach.
In the late 1980s, the antigens to which the
immune system reacts in VKH disease were identi-
fied, mostly from Japanese studies, as melanocyte-Fig. 12 Einosuke Harada (1892–1946)
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associated, based on the observation that T cells from
VKH patients were able to be cytotoxic against
human melanocytes and melanoma cells [27–28]. A
few years later, several groups identified some of the
potential antigens. In one report, the MART-1 peptide
was isolated as one of the candidates as cytotoxic T
lymphocytes recognizing MART-1 peptide were able
to lyse melanocytes [29]. Two other antigens subse-
quently identified were tyrosinase and tyrosinase-
related peptide (TRP) [30]. Similar results were
obtained by another group outside Japan which was
studying several antigens from the tyrosinase family
proteins [31]. Eye-infiltrating cells in VKH patients
were later found to react to the same antigens [32].
Since the mid-1990s, researchers have been able to
link VKH disease with the presence of the human
leukocyte antigen (HLA) DRB1*0405 [33–34], a
factor of increased severity in clinical disease and
increased T-cell reactivity in vitro [30–31].
More recently, significant progress has also been
achieved in monitoring the clinical manifestations of
the disease. As the primary target of the autoimmune
reaction is within the choroidal stroma, an investiga-
tional method able to show the choroidal structures
was needed to monitor disease evolution when the
disease was subclinical and confined to the choroid
after treatment had resolved the clinically apparent
inflammation. Indocyanine green angiography
(ICGA) was shown to be a very sensitive tool for
analyzing choroidal structures in inflammatory dis-
eases [35]. This tool is of particular use as applied to
VKH disease, which is an inflammatory disorder
primarily directed against choroidal structures, for
which detailed ICG angiography semiology has been
described [36]. It has even been shown that subclin-
ical recurrence of choroidal disease is detectable at
the time of tapering of inflammation suppressive
therapy, a disease recurrence that responded to
subsequent increase of therapy [37]. Optimalized
treatment can be expected with the help of ICG
angiography in the future.
Since 1999, a process aimed at a better defining
the disease was developed by Masahiko Usui and
Narsing Rao, resulting in workshops in Los Angeles
in 1999, Tokyo in 2001, Rome in 2003 and Monte
Carlo in 2005. New diagnostic criteria were issued
and these are presently being applied in the diagnosis
of VKH disease [38].
Conclusion
Vogt–Koyanagi–Harada disease has gone a long way
since its first description by Vogt in 1906, a century
ago, when it was called to the attention of the
ophthalmological community. The very characteristic
behavior of the disease, in contrast to more protean
disorders, has probably helped to define the disease
without too much delay, thanks to the work of
Yoshizo Koyanagi and Einosuke Harada. The char-
acteristic involvement of pigment-containing struc-
tures has allowed medical researchers to focus their
attention on this aspect of the disease and to identify
both risk factors and disease mechanisms. Diagnosis
is currently not a major problem, but treatment issues
remain, and improved therapy, aided by new sensitive
monitoring techniques, including ICG angiography
and possibly optical coherence tomography, may be
expected in the near future. Further progress in the
knowledge of the immunopathology of disease may
also result in a more targeted management.
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